You are here: Welcome » World Health Organization

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
world_health_organization [2022/10/14 21:39]
mathew 		world_health_organization [2023/07/04 22:17] (current)
liam [Donors]
Line 15: Line 15:
 On May 5, 2014, Director-General [[Margaret Chan]] declared the international spread of [[polio]] a [[Public Health Emergency of International Concern]] (PHEIC). The PHEIC declaration has remained in effect as of the most recent emergency committee meeting in June 2022.((//Public Health Emergency status.// Global Polio Eradication Initiative. Retrieved July 29, 2022, from https://web.archive.org/web/20220729220527/https://polioeradication.org/polio-today/polio-now/public-health-emergency-status/)) ((Poliovirus IHR Emergency Committee. (2022, June 24). //Statement of the Thirty-second Polio IHR Emergency Committee.// World Health Organization. https://web.archive.org/web/20220729220956/https://www.who.int/news/item/24-06-2022-statement-of-the-thirty-second-polio-ihr-emergency-committee)) On May 5, 2014, Director-General [[Margaret Chan]] declared the international spread of [[polio]] a [[Public Health Emergency of International Concern]] (PHEIC). The PHEIC declaration has remained in effect as of the most recent emergency committee meeting in June 2022.((//Public Health Emergency status.// Global Polio Eradication Initiative. Retrieved July 29, 2022, from https://web.archive.org/web/20220729220527/https://polioeradication.org/polio-today/polio-now/public-health-emergency-status/)) ((Poliovirus IHR Emergency Committee. (2022, June 24). //Statement of the Thirty-second Polio IHR Emergency Committee.// World Health Organization. https://web.archive.org/web/20220729220956/https://www.who.int/news/item/24-06-2022-statement-of-the-thirty-second-polio-ihr-emergency-committee))
  
-===== Pandemic Preparedness ===== +In 2019, the WHO published a [[pandemic preparedness]] document titled "[[https://web.archive.org/web/20220831234545if_/https://apps.who.int/iris/bitstream/handle/10665/329438/9789241516839-eng.pdf|Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza]]."((WHO Global Influenza Programme. (2019). //Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza.// World Health Organization. https://web.archive.org/web/20220831234545if_/https://apps.who.int/iris/bitstream/handle/10665/329438/9789241516839-eng.pdf))
-  * [[https://web.archive.org/web/20220831234545if_/https://apps.who.int/iris/bitstream/handle/10665/329438/9789241516839-eng.pdf|Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza]] (2019)+
  
 +=== COVID-19 ===
 +
 +On June 10, 2021, the WHO convened the [[2nd Global Consultation on SARS-CoV-2 Variants of Concern and their Impact on Public Health Interventions]].((//2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions.// (2021). World Health Organization. https://web.archive.org/web/20230312032446/https://www.who.int/docs/default-source/coronaviruse/report-sars-global-consultation_10june2021.pdf))
 +
 +In 2022, the WHO Regional Office for Europe published a document titled "Vaccine crisis communication manual: step-by-step guidance for national
 +immunization programmes."((Dolezal, K.-S. (2022). //Vaccine crisis communication manual: step-by-step guidance for national immunization programmes.// World Health Organization. https://web.archive.org/web/20230116172546/https://apps.who.int/iris/bitstream/handle/10665/352029/WHO-EURO-2022-3471-43230-60590-eng.pdf?sequence=1&isAllowed=y))
  
-===== Affiliations =====+===== Organization =====
  
 ==== Funding ==== ==== Funding ====
Line 68: Line 73:
   * [[Australian Red Cross Blood Service]] (ARCBS)   * [[Australian Red Cross Blood Service]] (ARCBS)
   * [[Australian Respiratory Council]]   * [[Australian Respiratory Council]]
-  * [[Bank of America Fondation Madagascar]]+  * [[Bank of Africa Fondation Madagascar]]
   * [[Barcelona Institute for Global Health]]   * [[Barcelona Institute for Global Health]]
   * [[pharmaceutical_companies:Baxter]]   * [[pharmaceutical_companies:Baxter]]
Line 139: Line 144:
   * [[Fondation Botnar]]   * [[Fondation Botnar]]
   * [[Fondation d'Harcourt]]   * [[Fondation d'Harcourt]]
-  * [[Fondation des Immeubles pour les Organisations Interrnationales]] (FIPOI)+  * [[Fondation des Immeubles pour les Organisations Internationales]] (FIPOI)
   * [[Fondation Mérieux]]   * [[Fondation Mérieux]]
   * [[Food and Agriculture Organization]] (FAO)   * [[Food and Agriculture Organization]] (FAO)
Line 183: Line 188:
   * [[International AIDS Society]] (IAS)   * [[International AIDS Society]] (IAS)
   * [[International Company for Medical Necessities]]   * [[International Company for Medical Necessities]]
-  * [[International Computing Centre]] (ICC) 
   * [[International Development Association]]   * [[International Development Association]]
   * [[International Development Law Organization]]   * [[International Development Law Organization]]
Line 350: Line 354:
   * [[United Nations Industrial Development Organization]] (UNIDO)   * [[United Nations Industrial Development Organization]] (UNIDO)
   * [[United Nations Institute for Training and Research]] (UNITAR)   * [[United Nations Institute for Training and Research]] (UNITAR)
 +  * [[United Nations International Computing Centre]] (UNICC)
   * [[United Nations Multidimensional Integrated Stabilization Mission in Mali]]   * [[United Nations Multidimensional Integrated Stabilization Mission in Mali]]
   * [[United Nations Office for Project Services]] (UNOPS)   * [[United Nations Office for Project Services]] (UNOPS)
Line 455: Line 460:
  
 Evaluation of ideas for potential platforms to support development and production of health technologies for priority infectious diseases with epidemic potential. Evaluation of ideas for potential platforms to support development and production of health technologies for priority infectious diseases with epidemic potential.
-After a brief overview of the WHO R&D Blueprint, information was provided on the [[:Coalition for+After a brief overview of the WHO [[R&D Blueprint]], information was provided on the [[:Coalition for
 Epidemic Preparedness Innovation]] (CEPI); and following a summary of the public consultation process Epidemic Preparedness Innovation]] (CEPI); and following a summary of the public consultation process
 since its launch, the six finalists (3 vaccines, 1 diagnostics, 1 immunotherapy, 1 covering all product since its launch, the six finalists (3 vaccines, 1 diagnostics, 1 immunotherapy, 1 covering all product
Back to top